StockData
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31

CNBX Pharmaceuticals Inc.

Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$197.79K
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

CNBX Pharmaceuticals has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements CNBX Pharmaceuticals filed with the SEC

  • CURRENT REPORT

    Event dated Sep 28, 2026, from SEC EDGAR

  • FORM 8-K

    Event dated Mar 10, 2026, from SEC EDGAR

  • FORM 8-K

    Event dated Jan 24, 2025, from SEC EDGAR

  • FORM 8-K

    Event dated Mar 18, 2024, from SEC EDGAR

  • CURRENT REPORT

    Event dated Jan 31, 2023, from SEC EDGAR

  • FORM 8-K

    Event dated Dec 25, 2022, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 20, 2022, from SEC EDGAR

  • FORM 8-K

    Event dated May 10, 2022, from SEC EDGAR

  • FORM 8-K

    Event dated Mar 28, 2022, from SEC EDGAR

  • FORM 8-K

    Event dated Mar 11, 2022, from SEC EDGAR

  • FORM 8-K

    Event dated Feb 15, 2022, from SEC EDGAR

  • CURRENT REPORT

    Event dated Nov 16, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Sep 3, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 15, 2021, from SEC EDGAR

  • FORM 8-K

    Event dated Jul 1, 2021, from SEC EDGAR